| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e85e3634bba46fb8073d591c37569fcd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc2dccf790967095919e4876347c9175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77d9c086364f33d5b4d40b3e6687e18c |
| publicationDate |
2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107793474-A |
| titleOfInvention |
A kind of antagonist of No. ten factor inhibitors class antithrombotic reagent side effects |
| abstract |
The present invention relates to the antagonist of a kind of No. ten factor inhibitors class antithrombotic reagent side effects.The present inventor is transformed No. ten factors of people using technique for gene engineering, obtains a kind of No. ten factors of saltant type.Compared with existing product, No. ten factors of saltant type of the invention have the advantages of safe, production procedure is simple, and production cost is low. |
| priorityDate |
2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |